To invest in a portfolio of North American securities. The current policy is to invest for capital growth without any distribution target.
Name | % Net Assets |
---|---|
Exxon Mobil | 3.9% |
Microsoft | 3.3% |
Merck & Co | 3.1% |
Cisco Systems | 3.0% |
Abbott Laboratories | 2.5% |
Procter & Gamble | 2.4% |
Merck & Co | 2.2% |
Hewlett Packard | 2.1% |
Abbott Laboratories | 1.9% |
Chevron | 1.9% |
Key | % Net Assets |
---|---|
Exxon Mobil | 3.9% |
Microsoft | 3.3% |
Merck & Co | 3.1% |
Cisco Systems | 3.0% |
Other | 86.7% |
Date | 09-Sep-2022 |
---|---|
NAV | 305.70p |
Currency | GBP |
Change | 1.10p |
% | 0.36% |
YTD change | 305.70p |
YTD % | n/a |
Fund Inception | 01/07/1995 |
---|---|
Fund Manager | Tom Luddy / Susan Bao |
TER | 1.68 (31-Jan-2013) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £100 |
Savings | n/a |
Charges | |
---|---|
Initial | 4.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research